SEQUENT SCIENTIFIC
Back to Balance Sheet
|
SEQUENT SCIENTIFIC Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹4.49 Cr | ₹4.33 Cr | ₹0.96 Cr | ₹1.67 Cr | ₹2.27 Cr |
What is the latest Contingent Liabilities ratio of SEQUENT SCIENTIFIC ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹4.49 Cr |
| Mar2024 | ₹4.33 Cr |
| Mar2023 | ₹0.96 Cr |
| Mar2022 | ₹1.67 Cr |
| Mar2021 | ₹2.27 Cr |
How is Contingent Liabilities of SEQUENT SCIENTIFIC Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.49 Cr | 3.79 | |
| Mar2024 | ₹4.33 Cr | 349.22 | |
| Mar2023 | ₹0.96 Cr | -42.20 | |
| Mar2022 | ₹1.67 Cr | -26.48 | |
| Mar2021 | ₹2.27 Cr | - | |
Compare Contingent Liabilities of peers of SEQUENT SCIENTIFIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SEQUENT SCIENTIFIC | ₹9,102.8 Cr | 0.7% | 6.3% | 52.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹399,549.0 Cr | 1% | -6.4% | -0.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,862.0 Cr | 3.5% | 3.4% | 11.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,912.0 Cr | 0.2% | -1.8% | 33.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,891.0 Cr | -0.2% | -3.4% | 11.4% | Stock Analytics | |
| CIPLA | ₹99,591.5 Cr | 1.5% | -5.4% | -15.4% | Stock Analytics | |
SEQUENT SCIENTIFIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SEQUENT SCIENTIFIC | 0.7% |
6.3% |
52.7% |
| SENSEX | 3.2% |
5% |
5.5% |
You may also like the below Video Courses